Communications Litigation Today was a Warren News publication.

DEA Adds Metonitazene to Schedule I Drug List

August 17, 2023 |Other U.S.

The Drug Enforcement Administration permanently placed the synthetic benzimidazol-opioid metonitazene on Schedule I of the Controlled Substances Act, it said in a final order released Aug. 17. The substance had already been temporarily listed in Schedule I since 2022 (see 2204110029). The final order is set to take effect Sept. 18.